T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Morningstar
MORN
$7.76B
| $14.2M | ﹤0.01% |
47,480
-621,409
| -93% | -$196M |
|
1027
Fluor
FLR
$7B
| $14.2M | ﹤0.01% |
396,485
+8,814
| +2% | +$381K |
|
1028
Nextpower Inc
NXT
$15.9B
| $14.2M | ﹤0.01% |
336,656
+8,016
| +2% | +$356K |
|
1029
Primoris Services
PRIM
$4.35B
| $14.1M | ﹤0.01% |
246,147
+166,162
| +208% | +$12M |
|
1030
Chemed
CHE
$7.02B
| $14M | ﹤0.01% |
22,824
-2,468
| -10% | -$1.4M |
|
1031
EPAM Systems
EPAM
$5.24B
| $14M | ﹤0.01% |
82,856
+1,217
| +1% | +$268K |
|
1032
Boston Properties
BXP
$11B
| $14M | ﹤0.01% |
207,920
+611
| +0.3% | +$42.8K |
|
1033
Check Point Software Technologies
CHKP
$13.7B
| $13.9M | ﹤0.01% |
60,984
+123
| +0.2% | +$26.1K |
|
1034
ePlus
PLUS
$2.31B
| $13.9M | ﹤0.01% |
227,173
+449
| +0.2% | +$31.8K |
|
1035
Amdocs
DOX
$6.23B
| $13.8M | ﹤0.01% |
150,339
+13,360
| +10% | +$1.17M |
|
1036
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $13.7M | ﹤0.01% |
247,240
| – | – |
|
1037
IMAX
IMAX
$2.92B
| $13.7M | ﹤0.01% |
518,314
+501,453
| +2,974% | +$12.5M |
|
1038
Alpha Metallurgical Resources
AMR
$1.97B
| $13.6M | ﹤0.01% |
108,792
+717
| +0.7% | +$117K |
|
1039
MongoDB
MDB
$38B
| $13.6M | ﹤0.01% |
77,486
-785,697
| -91% | -$191M |
|
1040
Alvotech
ALVO
$1.38B
| $13.6M | ﹤0.01% |
+1,401,421
| New | +$17M |
|
1041
Henry Schein
HSIC
$10B
| $13.5M | ﹤0.01% |
196,606
-1,534
| -0.8% | -$113K |
|
1042
Structure Therapeutics
GPCR
$3.89B
| $13.5M | ﹤0.01% |
777,173
-617,133
| -44% | -$15.1M |
|
1043
Centrus Energy
LEU
$3.83B
| $13.5M | ﹤0.01% |
216,225
-2,028
| -0.9% | -$171K |
|
1044
RB Global
RBA
$16B
| $13.4M | ﹤0.01% |
133,279
-54,750
| -29% | -$5.22M |
|
1045
Ingredion
INGR
$6.63B
| $13.4M | ﹤0.01% |
98,842
+2,631
| +3% | +$348K |
|
1046
Hormel Foods
HRL
$13.4B
| $13.3M | ﹤0.01% |
429,341
+6,852
| +2% | +$204K |
|
1047
Celsius Holdings
CELH
$7.28B
| $13.3M | ﹤0.01% |
372,008
-3,644,560
| -91% | -$99.3M |
|
1048
Herc Holdings
HRI
$5.64B
| $13.2M | ﹤0.01% |
98,427
+1,657
| +2% | +$282K |
|
1049
BHP
BHP
$222B
| $13.1M | ﹤0.01% |
268,872
-90,932
| -25% | -$4.53M |
|
|
BCYC
1050
Bicycle Therapeutics
BCYC
$279M
| $13M | ﹤0.01% |
1,536,584
-48,543
| -3% | -$572K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.